Kiniksa Pharmaceuticals International (KNSA) Receivables - Net (2021 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Receivables - Net came in at $23.5 million in Q2 2026, down 26.39% YoY from $31.9 million in Q2 2025, and up 1.15% on a QoQ basis from $23.2 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Receivables - Net (2021 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 6 years of Receivables - Net data on file, last reported at $23.5 million in Q2 2026.
- Quarterly Receivables - Net fell 26.39% year-over-year to $23.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $23.5 million (down 26.39% YoY) and the FY2025 annual result came in at $15.6 million, down 62.63% from the prior year.
- Receivables - Net grew to $23.5 million in Q2 2026, from $23.2 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $51.7 million in Q3 2025 to a low of $3.0 million in Q3 2023.
- A 5-year average of $22.6 million and a median of $22.2 million in 2023 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2023 — Receivables - Net tumbled 74.78% — and 2024, when it jumped 718.41%.
- Tracing KNSA's Receivables - Net over 5 years: stood at $12.7 million in 2022, then surged by 67.98% to $21.3 million in 2023, then soared by 96.2% to $41.7 million in 2024, then sank by 62.63% to $15.6 million in 2025, then soared by 50.63% to $23.5 million in 2026.
- The last three Receivables - Net figures came in at $23.5 million (Q2 2026), $23.2 million (Q1 2026), and $15.6 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 6.04 Bn | 5.52 Bn | 220.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.49 Mn |
| Jun 30, 2026 | 23.49 Mn |
| Mar 31, 2026 | 23.22 Mn |
| Mar 31, 2026 | 23.22 Mn |
| Dec 31, 2025 | 15.59 Mn |
| Dec 31, 2025 | 15.59 Mn |
| Sep 30, 2025 | 51.74 Mn |
| Sep 30, 2025 | 51.74 Mn |
| Jun 30, 2025 | 31.91 Mn |
| Jun 30, 2025 | 31.91 Mn |
| Mar 31, 2025 | 40.07 Mn |
| Mar 31, 2025 | 40.07 Mn |
| Dec 31, 2024 | 41.72 Mn |
| Dec 31, 2024 | 41.72 Mn |
| Sep 30, 2024 | 24.89 Mn |
| Sep 30, 2024 | 24.89 Mn |
| Jun 30, 2024 | 20.45 Mn |
| Jun 30, 2024 | 20.45 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Mar 31, 2024 | 16.00 Mn |